In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

In 2025, cannabis faces major changes with federal reclassification, easing regulations, increasing research, and opening ...

A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...

Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

The state's recreational cannabis industry has expanded to be one of the biggest cannabis markets in the country. Here's what 2025 will look like.

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...

Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...